FILAMIN TRANSLOCATION IS AN EARLY ENDOTHELIAL-CELL INFLAMMATORY RESPONSE TO BRADYKININ - REGULATION BY CALCIUM, PROTEIN-KINASES, AND PROTEIN PHOSPHATASES
Q. Wang et al., FILAMIN TRANSLOCATION IS AN EARLY ENDOTHELIAL-CELL INFLAMMATORY RESPONSE TO BRADYKININ - REGULATION BY CALCIUM, PROTEIN-KINASES, AND PROTEIN PHOSPHATASES, Journal of cellular biochemistry, 62(3), 1996, pp. 383-396
Endothelial cell (EC) cytoskeletal proteins are one of the earliest pr
imary targets of second messenger cascades generated in response to in
flammatory agonists. Actin binding proteins, by modulating actin gelat
ion-solation state and membrane-cytoskeleton interactions, in part reg
ulate cell motility and cell-cell apposition. This in turn can also mo
dulate interendothelial junctional diameter and permeability. Nonmuscl
e filamin (ABP-280), a dimeric actin-crosslinking protein, promotes or
thogonal branching of F-actin and links micro filaments to membrane gl
ycoproteins. In the present study, immunoblot analysis demonstrates th
at filamin protein levels are low in sparse EC cultures, increase once
cell-cell contact is initiated and then decrease slightly at post-con
fluency, Both bradykinin and ionomycin cause filamin redistribution fr
om the peripheral cell border to the cytosol of confluent EC. Forskoli
n, an activator of adenylate cyclase, blocks filamin translocation. Br
adykinin activation of EC is not accompanied by significant proteolyti
c cleavage of filamin. Instead, intact filamin is recycled back to the
membrane within 5-10 min of bradykinin stimulation. Inhibitors of cal
cium/calmodulin dependent protein kinase (KT-5926 and KN-62) attenuate
bradykinin-induced filamin translocation. H-89, an inhibitor of cAMP-
dependent protein kinase causes translocation of filamin in unstimulat
ed cells. Calyculin A, an inhibitor of protein phosphatases, also caus
es translocation of filamin in the absence of an inflammatory agent. M
L-7, an inhibitor of myosin light chain kinase and phorbol myristate a
cetate, an activator of protein kinase C, do not cause filamin movemen
t into the cytosol, indicating that these pathways do not modulate the
translocation. Pharmacological data suggest that filamin translocatio
n is initiated by the calcium/calmodulin-dependent protein kinase wher
eas the cAMP-dependent protein kinase pathway prevents translocation.
Inflammatory agents therefore may increase vascular junctional permeab
ility by increasing cytoplasmic calcium, which disassembles the microf
ilament dense peripheral band by releasing filamin from F-actin. (C) 1
996 Wiley-Liss, Inc.